BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou J, Sun H, Wang Z, et al. (2020) Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 9: 682-720 |
| Cai JL, Zhu GQ, Du JX, et al. (2020) Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices. Expert Review of Gastroenterology & Hepatology |
| Zhu GQ, Yu L, Zhou YJ, et al. (2020) Genetic Alterations and Transcriptional Expression of mA RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma. Frontiers in Oncology. 10: 900 |
| Zhou PY, Yang CP, Tang Z, et al. (2019) Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study. Aging. 11 |
| Hu JW, Yang ZF, Li J, et al. (2019) TGM3 promotes epithelial-mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver |
| Zhu K, Zhan H, Peng Y, et al. (2019) Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma. Carcinogenesis |
| Zhu K, Peng Y, Hu J, et al. (2019) Metadherin-PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT-β-catenin signaling pathway. Carcinogenesis |
| Zhu GQ, Yang Y, Chen EB, et al. (2019) Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17: 203 |
| Tian MX, Liu WR, Wang H, et al. (2019) Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. Bmc Medicine. 17: 106 |
| Zhu GQ, Zhou YJ, Qiu LX, et al. (2019) Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data. Carcinogenesis |